These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 24261922)

  • 21. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
    Wang Y; Yu L; Han L; Sha X; Fang X
    Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation.
    Qu G; Yao Z; Zhang C; Wu X; Ping Q
    Eur J Pharm Sci; 2009 May; 37(2):98-105. PubMed ID: 19429416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
    Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
    Meng L; Xia X; Yang Y; Ye J; Dong W; Ma P; Jin Y; Liu Y
    Int J Pharm; 2016 Nov; 513(1-2):8-16. PubMed ID: 27596118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.
    Chen FQ; Zhang JM; Fang XF; Yu H; Liu YL; Li H; Wang YT; Chen MW
    Acta Pharmacol Sin; 2017 Jun; 38(6):859-873. PubMed ID: 28260803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
    Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
    Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ
    Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
    Ji X; Gao Y; Chen L; Zhang Z; Deng Y; Li Y
    Int J Pharm; 2012 Jan; 422(1-2):390-7. PubMed ID: 22001531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
    Chavanpatil MD; Patil Y; Panyam J
    Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X; Sui M; Fan W
    Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
    Mo R; Xiao Y; Sun M; Zhang C; Ping Q
    Int J Pharm; 2011 May; 409(1-2):38-45. PubMed ID: 21356302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
    Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
    Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
    Wang C; Guo LB; Ma JY; Li YM; Liu HM
    Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles.
    Xiao L; Xiong X; Sun X; Zhu Y; Yang H; Chen H; Gan L; Xu H; Yang X
    Biomaterials; 2011 Aug; 32(22):5148-57. PubMed ID: 21546083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery.
    Pan Z; Gao Y; Heng L; Liu Y; Yao G; Wang Y; Liu Y
    Carbohydr Polym; 2013 Apr; 94(1):394-9. PubMed ID: 23544554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.